Nevoid basal cell carcinoma syndrome with cleft lip and palate associated with the novel PTCH gene mutations
Nevoid basal cell carcinoma syndrome with cleft lip and palate associated with the novel PTCH gene mutations
复制标题
DOI:
10.1038/jhg.2009.51
复制
发表时间:
2009-07
影响因子:
3.5
通讯作者:
R. Sasaki;Kayoko Saito;Yorikatsu Watanabe;Yoshinaga Takayama;K. Fujii;Kaori Agawa;T. Miyashita;T. Ando;T. Akizuki
中科院分区:
文献类型:
--
作者:
R. Sasaki;Kayoko Saito;Yorikatsu Watanabe;Yoshinaga Takayama;K. Fujii;Kaori Agawa;T. Miyashita;T. Ando;T. Akizuki
Nevoid basal cell carcinoma syndrome (NBCCS) is a rare autosomal dominant disorder characterized by developmental abnormalities and a predisposition to cancers. Two unrelated patients, 21-and 16-year-old males, with cleft lip and palate and multiple jaw cysts, were diagnosed according to clinical criteria. To confirm a diagnosis of NBCCS, we undertook a molecular genetic analysis of the PTCH gene. Their PTCH genes were analyzed by direct sequencing of the PCR product from their DNA, and previously unreported mutations were identified. A heterozygous duplication at the nucleotide position between 3325 and 3328 of the PTCH gene (c. 3325_3328dupGGCG) was detected in the 21-year-old patient. It caused a frameshift mutation, resulting in a premature termination of the PTCH protein. A point mutation (G to C) in intron 7 of the PTCH gene (c. 1067+ 1G> C) was detected in the 16-year-old patient. This caused an aberrant splicing of PTCH. It is interesting to note that the non-canonical cryptic splice-donor site was activated, which did not conform to the GT–AG rule.